Stock Events

Stock Events

CytomX Therapeutics (6C1.F) Q2 2026 Earnings

May 7Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.1

0.01

0.13

0.24

Details

Expected EPS

-0.10325918967

Actual EPS

-0.08526700000000001

Surprise EPS

0.02

Surprise Percent

+17.42%

Description

⁨CytomX Therapeutics⁩ (⁦6C1.F⁩) has reported earnings of ⁦-0.08526700000000001⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.